Chonnam National University Hospital
Gwangju, 61469, South Korea
Location status: Recruiting
Location contact
Seung Hun Lee, MD, PhD
CONTACT
Young Joon Hong, MD, PhD
CONTACT
Young Joon Hong, MD, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT05124249
To evaluate the long-term clinical outcomes and prognostic factors in patients with coronary artery disease (CAD) undergoing invasive coronary angiography (ICA), intravascular imaging, or invasive physiologic assessment.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Gwangju, 61469, South Korea
Location status: Recruiting
Seung Hun Lee, MD, PhD
CONTACT
Young Joon Hong, MD, PhD
CONTACT
Young Joon Hong, MD, PhD
PRINCIPAL_INVESTIGATOR
The traditional standard method for evaluating coronary artery disease (CAD) is invasive coronary angiography (ICA). ICA enables the assessment of anatomic severity of the epicardial artery and the severity of diameter stenosis can be closely associated with myocardial ischemia. However, there remains concern that anatomical severity is not always identical with functional significance. Actually, even the patients showed positive non-invasive tests including treadmill test, stress echocardiography, coronary computed tomography angiography, or nuclear imaging, less than half of the patients showed significant stenosis on ICA. Therefore, the investigators need further investigation to overcome the limitations of ICA.
In this regard, intravascular imaging, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), is a useful tool for assessing the anatomical severity in more detail. Those imaging modalities produce cross-sectional images of CAD and imaging modalities are allowing to assess lesion characteristics, plaque morphology, treatment planning, and optimization of the implanted stent. Furthermore, imaging-guided percutaneous coronary intervention (PCI) has been shown favorable outcomes, compared with angiography only-guided PCI, especially in complex lesions. Meanwhile, there has been an ample body of evidence that invasive coronary physiology assessment, such as fractional flow reserve (FFR), also can be useful for assessing the functional significance. Therefore, the current guidelines have continuously recommended intracoronary imaging and invasive physiologic assessment for guiding the treatment of CAD.
The aim of the IP-CAD (Imaging and Physiologic Evaluation of Coronary Artery Disease: a Prospective Registry Study) is to evaluate the long-term clinical outcomes according to the imaging-guided or physiology-guided PCI in real-world practice.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intravascular imaging (IVUS or OCT) or Invasive physiologic assessment
Patients who undergoing PCI
Time frame: 3-Year after the index procedure
a composite of all-cause death, myocardial infarction, or any revascularization
Time frame: 3-Year after the index procedure
death from any-cause
Time frame: 3-Year after the index procedure
death from cardiac-cause
Time frame: 3-Year after the index procedure
Myocardial infarction without peri-procedural myocardial infarction
Time frame: 3-Year after the index procedure
ischemia-driven or all
Time frame: 3-Year after the index procedure
ischemia-driven or all
Time frame: 3-Year after the index procedure
ischemia-driven or all
Time frame: 3-Year after the index procedure
definite or probable
Time frame: 3-Year after the index procedure
Ischemic or hemorrhagic stoke by braing imaging
Time frame: 3-Year after the index procedure
Bleeding Academic Research Consortium (BARC) type 2,3 or 5 bleeding
Time frame: 3-Year after the index procedure
a composite of all-cause death, myocardial infarction, any revascularization, and ischemic or hemorrhagic stroke
Contact information is provided by the study sponsor or research team.
Seung Hun Lee, MD, PhD
CONTACT
Young Joon Hong, MD, PhD
CONTACT
Chonnam National University Hospital
Other
Imaging and Physiologic Evaluation of Coronary Artery Disease: a Prospective Registry Study (IP-CAD)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05416385
Acute Coronary Syndrome, Arterial Occlusive Diseases
Calgary, Alberta, Canada
View Trial DetailsNCT06450561
Acute Coronary Syndrome, Arterial Occlusive Diseases
Sant Pere de Ribes, Barcelona, Spain
View Trial DetailsNCT05574621
Arterial Occlusive Diseases, Arteriosclerosis
Rome, Italy
View Trial DetailsNCT03855891
Arterial Occlusive Diseases, Arteriosclerosis
Moscow, Russia
View Trial Details